Evidence map›Paper›PMID 16679355›Full record

ReviewJournal of clinical pathology2006

Dynamic behavioural interpretation of cervical intraepithelial neoplasia with molecular biomarkers.

J P A Baak, A-J Kruse, S J Robboy, E A M Janssen, B van Diermen, I Skaland

Abstract readReview
In one paragraph

Review in Journal of clinical pathology, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. p16Clinical and translational medicine · 2023
    Article
  6. Observational
  7. Article
  8. Article
  9. Article
  10. Role ofBMJ open · 2019
    Observational
  11. Article
  12. Article
  13. Article
  14. HPV E4 expression and DNA hypermethylation of CADM1, MAL, and miR124-2 genes in cervical cancer and precursor lesions.Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc · 2018
    Article
  15. Three-tiered score for Ki-67 and p16Journal of clinical pathology · 2018
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

J P A BaakStovagen University Hospital and the Gade Institute, University of Bergen, Bergen, Norway. baja@sos.no
A-J Kruse
S J Robboy
E A M Janssen
B van Diermen
I Skaland

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The microscopic phenotype of cervical intraepithelial neoplasia (CIN) reflects a fine balance between factors that promote or reduce CIN development. A shortcoming of the current grading system is its reliance on static morphology and microscopic haematoxylin-eosin features of the epithelium alone. In reality, CIN is a dynamic process, and the epithelium may exhibit differing results over time. Functional biomarkers p16, Ki-67, p53, retinoblastoma protein cytokeratin (CK)14 and CK13, help in the assessment of an individual CIN's lesion's potential for progression and regression. The aggregate information provided by these biomarkers exceeds the value of the classic grading system. Consequently, many more CINs that will either regress or progress can be accurately identified. These findings agree with known molecular interactions between HPV and the host. For accurate interpretation of a CIN, it is essential that these biomarkers be determined quantitatively and separately in the superficial, middle and deep layers of the epithelium. Such geography-specific epithelial evaluations of quantitative biomarkers emphasise the dynamic nature of a particular CIN lesion, thereby changing the art of static morphology grading into dynamic interpretation of the diseased tissue, with a strong prognostic effect.

Indexed as

Biomarkers, TumorCyclin-Dependent Kinase Inhibitor p16Disease ProgressionFemaleHumansKi-67 AntigenPapillomavirus InfectionsUterine Cervical DysplasiaUterine Cervical NeoplasmsBiomarkers, TumorCyclin-Dependent Kinase Inhibitor p16Ki-67 Antigen

Identifiers

PMID16679355
PMCPMC1861745

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.